Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -36.17% is 42% above its 5-year average of -62.07%, near the high end of its 5-year range (-332.72%–0.00%).
As of the fiscal period ended Tuesday, March 31, 2026. 57.16% below its 12-month average of -23.02%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
-36.17%
NET PROFIT MARGIN AVG TTM
-23.02%
NET PROFIT MARGIN AVG 3Y
-30.88%
NET PROFIT MARGIN AVG 5Y
-47.03%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-57.16%
CURRENT VS 3Y AVG
-17.15%
CURRENT VS 5Y AVG
+23.09%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
10.44%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-446.47%
vs the sector median at left
Tempus AI, Inc.
Market Cap
$7.48B
Net Profit Margin
-36.17%
TTM Avg
-23.02%
3Y Avg
-30.88%
5Y Avg
-47.03%
Market Cap
$7.50B
Net Profit Margin
-0.30%
TTM Avg
-1.75%
3Y Avg
-5.71%
5Y Avg
-20.27%
Market Cap
$6.58B
Net Profit Margin
-0.56%
TTM Avg
7.00%
3Y Avg
-0.29%
5Y Avg
-8.82%
Market Cap
$8.61B
Net Profit Margin
6.52%
TTM Avg
-21.22%
3Y Avg
-48.94%
5Y Avg
16.61%
Market Cap
$9.75B
Net Profit Margin
2.95%
TTM Avg
3.05%
3Y Avg
3.43%
5Y Avg
3.79%
Market Cap
$10.10B
Net Profit Margin
8.56%
TTM Avg
7.89%
3Y Avg
6.46%
5Y Avg
6.98%
Market Cap
$10.37B
Net Profit Margin
-4.07%
TTM Avg
-4.03%
3Y Avg
-0.72%
5Y Avg
0.14%
Market Cap
$10.61B
Net Profit Margin
-0.02%
TTM Avg
1.97%
3Y Avg
2.41%
5Y Avg
2.58%
Market Cap
$10.84B
Net Profit Margin
-4.59%
TTM Avg
-1.67%
3Y Avg
5.09%
5Y Avg
7.31%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $7.48B | -36.17% | -23.02% | -30.88% | -47.03% |
| Oscar Health, Inc. (OSCR)vs › | $7.50B | -0.30% | -1.75% | -5.71% | -20.27% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.58B | -0.56% | 7.00% | -0.29% | -8.82% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.61B | 6.52% | -21.22% | -48.94% | 16.61% |
| Henry Schein, Inc. (HSIC)vs › | $9.75B | 2.95% | 3.05% | 3.43% | 3.79% |
| Universal Health Services, Inc. (UHS)vs › | $10.10B | 8.56% | 7.89% | 6.46% | 6.98% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -4.07% | -4.03% | -0.72% | 0.14% |
| Molina Healthcare, Inc. (MOH)vs › | $10.61B | -0.02% | 1.97% | 2.41% | 2.58% |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.84B | -4.59% | -1.67% | 5.09% | 7.31% |
| Bio-Techne Corporation (TECH)vs › | $11.23B | 9.05% | 10.26% | 17.56% | 19.39% |
Operating Margin
-18.1%
Net Profit Margin
-36.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | -36.17% |
| 2025-12-31 | -14.75% |
| 2025-09-30 | -23.93% |
| 2025-06-30 | -13.62% |
| 2025-03-31 | -26.60% |
| 2024-12-31 | -6.48% |
| 2024-09-30 | -41.92% |
| 2024-06-30 | -332.72% |
| 2024-03-31 | -44.40% |
| 2023-12-31 | -34.17% |
| 2023-09-30 | -39.27% |
| 2023-06-30 | -42.16% |
| 2023-03-31 | -47.03% |
| 2022-12-31 | -65.66% |
| 2022-09-30 | 0.00% |
| 2021-12-31 | -80.45% |
| 2021-09-30 | -130.30% |
| 2021-06-30 | -99.83% |
| 2021-03-31 | -99.83% |
| 2020-12-31 | -53.68% |
| 2020-09-30 | -113.36% |
| 2020-06-30 | -269.64% |
| 2020-03-31 | -269.64% |
